The filing

Intimation of proposal of merger of two wholly owned stepdown subsidiaries with a wholly owned subsidiary.

Company

Aurobindo Pharma Ltd · BSE 524804

Filed

5 August 2026, 20:09 IST

BSE category

Company Update / Restructuring

Tag

Restructuring · selected

Source

Open the filing on BSE →

Why it led

• Restructuring is rare - fewer than one filing in two hundred
• First Restructuring from this company — not seen in the 68 trading days on record
• Mid cap · NIFTY 500
• 4 filings today

Selected by the ranker from 56 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

65 of 83,122 filings in the published window carry Restructuring · 0.08%

Around it

Also filed by Aurobindo Pharma Ltd on 5 August 2026

• Press Release / Media Release Press Release
• Investor Presentation Investor Presentation
• Board Meeting Outcome for Outcome Of The Board Meeting Held On August 5, 2026 Board Outcome

Most recent filings from Aurobindo Pharma Ltd

• Newspaper Publication Newspaper Publication 3 September 2026
• Acquisition Subsidiary Incorporation 1 September 2026
• Press Release / Media Release (Revised) Press Release 31 August 2026